Abstract:Aging HSCs display a progressive and growth-factor sensitive elongation of G 1 . Increased growth-factor concentrations are required to stimulate mitogenesis in aging HSCs associated with reduced AKT activation. Human hematopoietic stem cells (HSCs), like their counterparts in mice, comprise a functionally and molecularly heterogeneous population of cells throughout life that, collectively, maintain required outputs of mature blood cellsunder homeostatic conditions. An early developmental change in the HSC population in both species includes a postnatal switch from most of these cells existing in a rapidly cycling state and maintenance of a high self-renewal potential to a majority in a quiescent state with an overall reduced self-renewal potential. However, despite the well-established growth factor dependence of HSC proliferation, if and how this mechanism of HSC regulation might be affected by aging has remained poorly understood. To address this gap, we isolated highly HSC-enriched CD34+CD38-CD45RA-CD90+CD49f+ (" CD49f+ ") cells from cord blood and adult bone marrow and mobilized peripheral blood samples obtained from normal humans spanning 7 decades of age and then measured their functional and molecular responses to growth-factor stimulation in vitro and regenerative activity in vivo in transplanted mice. Initial experiments revealed advancing donor age was accompanied by a significant and progressively delayed proliferative response but not the altered mature cell outputs seen in normal older individuals. Importantly, subsequent dose-response analyses revealed an age-associated reduction in the growth-factor stimulated proliferation of CD49f+ cells mediated by reduced intrinsic activation of AKT and altered cell-cycle entry and progression. These findings identify a new intrinsic, pervasive, and progressive aging-related alteration in the biological and signaling mechanisms required to drive the proliferation of very primitive normal human hematopoietic cells.

Genotoxic aldehyde stress prematurely ages hematopoietic stem cells in a p53-driven manner

3216 – GENOTOXIC FORMALDEHYDE ACCELERATES AGEING IN HEMATOPOIETIC STEM CELLS IN A P53-DRIVEN MANNER

Sirt1 Protects Subventricular Zone-Derived Neural Stem Cells from DNA Double-Strand Breaks and Contributes to Olfactory Function Maintenance in Aging Mice

Senescence Reprogramming by MTHFD2 Deficiency Facilitates Tumor Progression

P53-Tp53-induced Glycolysis Regulator Mediated Glycolytic Suppression Attenuates DNA Damage and Genomic Instability in Fanconi Anemia Hematopoietic Stem Cells

DNA methylation drives hematopoietic stem cell aging phenotypes after proliferative stress

Aging of hematopoietic stem cells: DNA damage and mutations?

Hematopoietic Stem Cell Aging and Fate Decision

Pulmonary Alveolar Stem Cell Senescence, Apoptosis, and Differentiation by p53-Dependent and -Independent Mechanisms in Telomerase-Deficient Mice

Aging alters the cell cycle control and mitogenic signaling responses of human hematopoietic stem cells

DNA Damage Response in Hematopoietic Stem Cell Ageing

Aging limits stemness and tumorigenesis in the lung by reprogramming iron homeostasis

Loss of p53-mediated cell-cycle arrest, senescence and apoptosis promotes genomic instability and premature aging

An epigenetic component of hematopoietic stem cell aging amenable to reprogramming into a young state

Aging is associated with functional and molecular changes in distinct hematopoietic stem cell subsets

Immunoaging induced by hematopoietic stem cell aging.

Fine-tuning P53 Activity Through C-terminal Modification Significantly Contributes to HSC Homeostasis and Mouse Radiosensitivity.

Two Aldehyde Clearance Systems Are Essential to Prevent Lethal Formaldehyde Accumulation in Mice and Humans

Telomere Dysfunction and Cell Cycle Checkpoints in Hematopoietic Stem Cell Aging

Age-related Noncanonical TRMT6–TRMT61A Signaling Impairs Hematopoietic Stem Cells

Genotoxic aldehydes in the hematopoietic system